Tornier Perform Reversed Augmented Glenoid
Device Bone Substitute
PDI 00846832092079
General payments
$1,636,177
Research payments
$226,606
Through program year 2025, $1,636,177 in general payments and $226,606 in research payments were reported against Tornier Perform Reversed Augmented Glenoid (Bone Substitute).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $200,736 | 389 |
| 2025 | Research | $89,907 | 8 |
| 2024 | General | $975,264 | 517 |
| 2024 | Research | $54,842 | 10 |
| 2023 | General | $396,795 | 231 |
| 2023 | Research | $59,514 | 13 |
| 2022 | General | $63,382 | 91 |
| 2022 | Research | $22,342 | 3 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 16 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 31 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,228 general · 34 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.